BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 23974296)

  • 21. The dye SYPRO orange binds to amylin amyloid fibrils but not pre-fibrillar intermediates.
    Wong AG; Raleigh DP
    Protein Sci; 2016 Oct; 25(10):1834-40. PubMed ID: 27479186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus.
    Westermark P; Andersson A; Westermark GT
    Physiol Rev; 2011 Jul; 91(3):795-826. PubMed ID: 21742788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous amylin fibril growth mechanisms imaged by total internal reflection fluorescence microscopy.
    Patil SM; Mehta A; Jha S; Alexandrescu AT
    Biochemistry; 2011 Apr; 50(14):2808-19. PubMed ID: 21391619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural polymorphism of human islet amyloid polypeptide (hIAPP) oligomers highlights the importance of interfacial residue interactions.
    Zhao J; Yu X; Liang G; Zheng J
    Biomacromolecules; 2011 Jan; 12(1):210-20. PubMed ID: 21158384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of thioflavin T binding to amyloid fibrils.
    Khurana R; Coleman C; Ionescu-Zanetti C; Carter SA; Krishna V; Grover RK; Roy R; Singh S
    J Struct Biol; 2005 Sep; 151(3):229-38. PubMed ID: 16125973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.
    Aitken JF; Loomes KM; Konarkowska B; Cooper GJ
    Biochem J; 2003 Sep; 374(Pt 3):779-84. PubMed ID: 12812521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physico-chemical properties of co-formulated fast-acting insulin with pramlintide.
    da Silva DC; Lima LMTR
    Int J Pharm; 2018 Aug; 547(1-2):621-629. PubMed ID: 29928940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers.
    Liang G; Zhao J; Yu X; Zheng J
    Biochemistry; 2013 Feb; 52(6):1089-100. PubMed ID: 23331123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dynamics simulation study on the molecular structures of the amylin fibril models.
    Xu W; Su H; Zhang JZ; Mu Y
    J Phys Chem B; 2012 Dec; 116(48):13991-9. PubMed ID: 23145779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions.
    Susa AC; Wu C; Bernstein SL; Dupuis NF; Wang H; Raleigh DP; Shea JE; Bowers MT
    J Am Chem Soc; 2014 Sep; 136(37):12912-9. PubMed ID: 25144879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol regulates assembly of human islet amyloid polypeptide on model membranes.
    Cho WJ; Trikha S; Jeremic AM
    J Mol Biol; 2009 Oct; 393(3):765-75. PubMed ID: 19720065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.
    Meng F; Abedini A; Plesner A; Verchere CB; Raleigh DP
    Biochemistry; 2010 Sep; 49(37):8127-33. PubMed ID: 20707388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro.
    Exley C; House E; Patel T; Wu L; Fraser PE
    J Inorg Biochem; 2010 Oct; 104(10):1125-9. PubMed ID: 20579740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro.
    Kayed R; Bernhagen J; Greenfield N; Sweimeh K; Brunner H; Voelter W; Kapurniotu A
    J Mol Biol; 1999 Apr; 287(4):781-96. PubMed ID: 10191146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Watching amyloid fibrils grow by time-lapse atomic force microscopy.
    Goldsbury C; Kistler J; Aebi U; Arvinte T; Cooper GJ
    J Mol Biol; 1999 Jan; 285(1):33-9. PubMed ID: 9878384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the Effect of Pyrogallol on the Formation of Amylin Amyloid Fibrils as a Strategy for the Treatment of Type 2 Diabetic Patients: A Theoretical and Experimental Study.
    Bahramikia S; Shirzadi N; Pirmohammadi N
    J Fluoresc; 2024 Jan; 34(1):245-251. PubMed ID: 37195541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NFGAIL Amyloid Oligomers: The Onset of Beta-Sheet Formation and the Mechanism for Fibril Formation.
    Hoffmann W; Folmert K; Moschner J; Huang X; von Berlepsch H; Koksch B; Bowers MT; von Helden G; Pagel K
    J Am Chem Soc; 2018 Jan; 140(1):244-249. PubMed ID: 29235867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cosolvent effects on the fibrillation reaction of human IAPP.
    Seeliger J; Estel K; Erwin N; Winter R
    Phys Chem Chem Phys; 2013 Jun; 15(23):8902-7. PubMed ID: 23493869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orientations of residues along the β-arch of self-assembled amylin fibril-like structures lead to polymorphism.
    Wineman-Fisher V; Atsmon-Raz Y; Miller Y
    Biomacromolecules; 2015 Jan; 16(1):156-65. PubMed ID: 25420121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
    Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
    J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.